iShares MSCI India ETF vs Vital Farms Inc — how do they compare? iShares MSCI India ETF trades at $46.03 (market cap $5.73B), while Vital Farms Inc trades at $9.33 (market cap $405.27M). The key difference: iShares MSCI India ETF is far larger — about 14.1× Vital Farms Inc's market cap, and iShares MSCI India ETF is more actively traded (6,797,522 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 58 Days and Vital Farms Inc for 14 Days on average.
| INDA | VITL | |
|---|---|---|
Market Cap | $5.73B | $405.27M |
Volume | 6,797,522 | 1,810,837 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $55.29 | $43.40 |
52-Week Low | $45.42 | $8.28 |
Typical Hold Time | 58 Days | 14 Days |
Enterprise Value | — | $492.28M |
Signals from Pluang's Aura AI — not financial advice
INDA trades at $45.56, down 1.21% with bearish technical signals dominating. The ETF faces headwinds from India's economic challenges including coal power shortages, below-average monsoon rains, and IT sector weakness. Technical indicators show oversold conditions with RSI readings below 20, while moving averages signal strong bearish momentum. Recent news highlights energy security concerns and pharmaceutical export challenges affecting the underlying Indian market exposure.
The outlook remains cautious given multiple sector-specific pressures in India. Investment opportunity exists for long-term investors betting on India's growth story at depressed levels, but risks include persistent energy shortages, agricultural output concerns, and global trade tensions that could further pressure the ETF's performance in the near term.
Vital Farms (VITL) trades at $9.435, up 2.11% today, amid a challenging period marked by volatile earnings and a bearish technical signal. The stock shows weak profitability with a net income margin of 0.02% in 2026, though valuation ratios like P/S of 0.55 appear attractive. Recent news highlights strategic review for a potential sale, with price targets ranging from $10 to $20. Cash flow remains negative, driven by heavy investing activities, while institutional interest persists with new acquisitions.
The outlook is mixed: analyst consensus is bullish with a $13.11 target, but near-term risks include pricing pressure in the egg market and earnings volatility. Recovery hinges on stabilizing supply costs and executing strategic options. Investors should weigh low valuation against operational challenges and industry headwinds for potential upside.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →